Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors


FDA approves Symplicity Spyral renal denervation (RDN) system for treatment of hypertension – Medtronic

Written by | 26 Nov 2023

Medtronic plc announced that the FDA has approved the Symplicity Spyral renal denervation (RDN) system, also known as the Symplicity blood pressure procedure, for the treatment of hypertension…. read more.

CE Mark for Simplera continuous glucose monitor (CGM) featuring a simple, two-step insertion process – Medtronic

Written by | 4 Oct 2023

Medtronic plc announced CE (Conformité Européenne) Mark approval for its new all-in-one, disposable Simplera continuous glucose monitor (CGM) featuring a simple, two-step insertion process. The company’s newest no-fingerstick… read more.

Inceptiv spinal cord stimulator with closed-loop sensing to treat chronic pain receives CE Mark – Medtronic plc

Written by | 29 Aug 2023

Medtronic plc has received CE (Conformité Européenne) Mark approval for its Inceptiv closed-loop rechargeable spinal cord stimulator (SCS). It is the first Medtronic SCS device to offer a… read more.

Medtronic recalls nearly 350,000 defibrillators for risk of reduced shock

Written by | 26 Jul 2023

The FDA has identified a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death.;Recalled Product Product Names: Cobalt… read more.

Medtronic receives FDA expanded approval for cardiac cryoablation catheters for pediatric treatment of a common heart rhythm condition

Written by | 16 Aug 2022

Medtronic plc a global leader in healthcare technology, announced that the Freezor and Freezor Xtra Cardiac Cryoablation Catheters are approved by the FDA and are the only ablation… read more.

Hugo Robotic-Assisted Surgery System receives European CE Mark approval – Medtronic

Written by | 14 Oct 2021

Medtronic plc announced it has received CE (Conformité Européenne) Mark for the Hugo robotic-assisted surgery (RAS) system, authorizing the sale of the system in Europe. CE Mark approval… read more.

Medtronic announces NAVABLATE study results with the Emprint Ablation Catheter Kit for bronchoscopic ablation at the European Respiratory Society International Congress 2021

Written by | 10 Oct 2021

Medtronic plc has announced new clinical data from the NAVABLATE study, which highlights the much anticipated safety and performance results on microwave ablation used bronchoscopically with the Emprint… read more.

Medtronic stops distribution of HeartWare HVAD system in United States

Written by | 18 Jun 2021

The FDA is alerting health care providers to no longer implant end-stage heart failure patients with Medtronic’s Heartware Ventricular Assist Device (HVAD) System due to a growing body… read more.

FDA approves Vanta, a recharge-free implantable neurostimulator for chronic pain – Medtronic

Written by | 16 Jun 2021

Medtronic plc announced it has received FDA approval for Vanta, a high performance recharge-free implantable neurostimulator (INS) with a device life that can be optimized up to 11… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.


You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.